PD-L1

Have antibodies to Alzheimer's been discovered? Illustration: depositphotos.com.

Experimental Alzheimer's antibody passes first safety test

The antibody IBC-Ab002, based on research by Prof. Michal Schwartz of the Weizmann Institute of Science, was tested in 40 patients in the early stages of the disease. The treatment was found to be safe and tolerable at the doses tested and led to changes in biomarkers, but
A sample from a tumor of a human patient with the most common lung cancer (adenocarcinoma). The presence of senescent cells expressing the proteins P16 (in red) and PD-L1 (in green) can be detected. The cell nuclei in the sample are marked in blue

to open blockages in the immune system

Photomicrograph of a biopsy from a patient's lungs. Illustration: depositphotos.com

Towards a new generation of treatments for old age diseases